Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03319485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03319485 · ClinicalTrials.gov record · last posted 2026-03-20

ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started2018-02-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Evaluate the safety and efficacy of unilateral focused ultrasound pallidotomy using the ExAblate 4000 System in the management of dyskinesia symptoms or motor fluctuations for medication refractory, advanced idiopathic Parkinson's disease.

Amendment record 27 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 27 times since 2017-10-23; most recent amendment 2026-03-18. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2020-05-21
Status change Recruiting→Active, Not Recruitingv23
2018-02-08
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT03319485
Lead Sponsor InSightec
Conditions Parkinson Disease
Enrollment 92 participants
Start Date 2018-02-09
Primary Completion 2024-07-25 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-20